p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes by Perearnau Garcia, Anna et al.
5086–5099 Nucleic Acids Research, 2017, Vol. 45, No. 9 Published online 3 February 2017
doi: 10.1093/nar/gkx075
p27Kip1, PCAF and PAX5 cooperate in the
transcriptional regulation of specific target genes
Anna Perearnau1, Serena Orlando1, Abul B.M.M.K. Islam2, Edurne Gallastegui1,
Jonatan Martı´nez1, Albert Jordan3, Anna Bigas4, Rosa Aligue´1, Maria Jesu´s Pujol1 and
Oriol Bachs1,*
1Department of Biomedical Sciences, University of Barcelona-IDIBAPS, CIBERONC, 08036 Barcelona, Spain,
2Department of Genetic Engineering and Biotechnology University of Dhaka, Dhaka 1000, Bangladesh, 3Department
of Molecular Genomics, Molecular Biology Institute of Barcelona (IBMB), Consejo Superior de Investigaciones
Cientı´ficas (CSIC), 08029 Barcelona, Spain and 4Program in Cancer Research, Institut Hospital del Mar
d’Investigacions Me`diques (IMIM), CIBERONC, 08003 Barcelona, Spain
Received May 29, 2015; Revised January 24, 2017; Editorial Decision January 25, 2017; Accepted January 26, 2017
ABSTRACT
The cyclin-dependent kinase inhibitor p27Kip1 (p27)
also behaves as a transcriptional repressor. Data
showing that the p300/CBP-associated factor
(PCAF) acetylates p27 inducing its degradation sug-
gested that PCAF and p27 could collaborate in the
regulation of transcription. However, this possibility
remained to be explored. We analyzed here the tran-
scriptional programs regulated by PCAF and p27 in
the colon cancer cell line HCT116 by chromatin im-
munoprecipitation sequencing (ChIP-seq). We iden-
tified 269 protein-encoding genes that contain both
p27 and PCAF binding sites being the majority of
these sites different for PCAF and p27. PCAF or p27
knock down revealed that both regulate the expres-
sion of these genes, PCAF as an activator and p27
as a repressor. The double knock down of PCAF and
p27 strongly reduced their expression indicating that
the activating role of PCAF overrides the repressive
effect of p27. We also observed that the transcrip-
tion factor Pax5 interacts with both p27 and PCAF
and that the knock down of Pax5 induces the ex-
pression of p27/PCAF target genes indicating that
it also participates in the transcriptional regulation
mediated by p27/PCAF. In summary, we report here
a previously unknown mechanism of transcriptional
regulation mediated by p27, Pax5 and PCAF.
INTRODUCTION
The protein p27Kip1 (p27) is a member of the Cip/Kip fam-
ily of cyclin dependent kinase (Cdk) inhibitors that also in-
cludes p21Cip1 and p57Kip2 (1). Its classical role is to inhibit
the activity of most cyclin–Cdk complexes involved in cell
cycle progression. It interacts with both cyclin andCdk sub-
units by the KID domain sited on its amino moiety (2).
The KID consists of three subdomains: the cyclin-binding
subdomain (D1), the Cdk-binding subdomain (D2) and a
linker subdomain that joins D1 and D2 (3). Phosphoryla-
tion of specific tyrosine residues in the D2 subdomain (Y74
and Y88), by members of the Src family of kinases, allows
the partial activation of the Cdk in the trimeric complexes
formed by cyclin, Cdk and p27 (4, 5). Thus, p27 behaves as a
dual regulator of cyclin–Cdk complexes by inhibiting their
activities in the non-tyrosine phosphorylated form and al-
lowing Cdk to be active when phosphorylated at these spe-
cific tyrosine residues.
p27 directly interacts with the acetyltransferase and
transcriptional co-activator p300/CBP associated factor
(PCAF) by a region (aa 91–120) containing a proline rich
domain (PRD, aa 91–96) included in the D2 subdomain
of p27 (6). PCAF interacts with p27 by its catalytic do-
main and acetylates p27 at Lysine 100, very close to the
PRD. This acetylation induces its ubiquitylation and the
subsequent degradation via proteasome (6). Thus, Src ki-
nases and PCAF regulate cell cycle progression by generat-
ing post-translational modifications of p27 that lead to the
activation of cyclin–Cdk complexes.
p27 also plays a role as a transcriptional regulator (7–
9). It associates with a number of gene promoters through
E2F4/p130 complexes behaving as a transcriptional repres-
sor of these genes (9). The specific role of p27 on these re-
pressor complexes is to recruit cyclin D2/D3–Cdk4 com-
plexes needed for p130 phosphorylation at early-mid G1
phase (10). This possibility is supported by the fact that
the interaction of p27 with E2F4 and p130 is through its
carboxyl-moiety (9) indicating that the KID subdomain in
the NH2 region will be free to associate with cyclin–Cdk
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complexes when they appear at early G1. The role of p27 as
a transcriptional repressor mediated by E2F4/p130 com-
plexes has been confirmed by a recent work showing that
p27 represses transcription of SOX2 through this mecha-
nism (11).
p27 deficiency is associated with tumorigenesis and re-
duced p27 levels are frequently observed in human cancers
in association with tumor aggressiveness and poor clini-
cal outcome (12–14). In most of the cases, low p27 levels
are due to post-transcriptional mechanisms that induce its
proteasome-dependent degradation (15, 16). Interestingly,
the over-expression of p27-target genes (p27-TGs) in hu-
man tumors correlates with poor clinical outcome suggest-
ing that the transcriptional regulatory function of p27 plays
an important role in tumor development (9). Thus, to un-
derstand how p27 regulates transcription is an important
goal to be achieved not only to better define themechanisms
involved in cell cycle regulation but also the role of p27 in
tumorigenesis.
The evidence that the transcriptional co-activator PCAF
acetylates the repressor p27 inducing its degradation (6)
led us to investigate whether these two proteins collaborate
in the regulation of gene expression. We performed chro-
matin immunoprecipitation sequencing (ChIP-seq) analysis
to identify the putative transcriptional programs regulated
by these two proteins. We selected a number of targets com-
mon to both proteins and analyzed themechanism bywhich
p27 and PCAF regulate the transcription of these genes. In-
terestingly, we found that the transcription factor PAX5 in-
teracts with both p27 and PCAF and also participates in
the transcriptional regulation of p27/PCAF target genes.
MATERIALS AND METHODS
Antibodies
Antibodies against p27 (ChIP and IP) (sc-528), PAX-5
(WB) (sc-13146), PAX-5 (WB) (sc-1974), UNC5D (WB)
(anti-UNC5H4, sc-135262), PCAF (WB) (sc-13124), SPAG
9 (WB) (anti- JIP-4, sc-134972) and ROBO1 (WB) (sc-
25672) were from Santa Cruz. p27 antibody (WB) (610242)
was from BD Transduction Laboratories. Antibodies
against PCAF (WB) (P7493) and tubulin (WB) (T9026)
were from Sigma. Antibodies against PCAF (ChIP/IP)
(ab12188) and PAX-5 (ChIP/IP, WB) (ab15164) were from
Abcam. GRIN3A antibodies (WB) (MA1-10881) were
from Thermo Fisher Scientific and actin antibody (WB)
(0869100) was obtained from MP Biomedicals.
Cell cultures
HCT116 cells were cultured in Dulbecco’s modified Ea-
gle’s medium (DMEM)–HAM F12 (1:1). MCF-7 cells and
mice embryonic fibroblasts (MEFs) WT and p27−/− were
cultured in DMEM supplemented with 10% fetal bovine
serum, 2 mM glutamine, 1% non-essential amino acids, 1
mM pyruvic acid and 5% penicillin/streptomycin. Cultures
were maintained at 37◦C and 5% CO2.
Determination of generation time
Generation time was determined in HCT116 Control, p27
and PCAF cells transfected with the CRISPR plasmid as
described in CRISPR/Cas9 transfection section. Cells were
seeded at a density of 300 000 cells per 60 mm dish to deter-
mine their proliferation. We calculated the rate of growth of
each cell line by counting the total number of viable cells in
duplicate dishes for 24, 48, 72 and 96 h with the Scepter™
2.0 Cell Counter (Millipore).
Immunoprecipitation
Asynchronously growing HCT116 cells were scraped and
washed twice with PBS. Pellets were lysed in 1 ml of im-
munoprecipitation (IP) buffer (PBS containing 0.5% Tri-
ton X-100, 1 mM EDTA, 100 M sodium orthovanadate,
0.25 mM PMSF, 20 mM  glycerol phosphate, complete
protease inhibitor mixture by Roche Applied Science, and
1/25 vol of DNAse I) (Sigma). Cell lysates were incubated
for 15 min rotating at RT and 15 min on ice. Then, they
were centrifuged at 3000 rpm at 4◦C for 5 min. After cen-
trifugation, samples were subsequently quantified using the
Lowry method (17). 1 mg of total protein was incubated
overnight at 4◦C with 2–4 g of antibodies (PAX5, p27 or
PCAF). Proteins and antibody were incubated with pro-
teinA-Dynabeads (Invitrogen) for 1 h and the immunocom-
plexes were extensively washed with IP buffer. Subsequently
they were eluted by boiling at 100◦C in Laemmli buffer for
western blot (WB) analysis. As a control, lysates were incu-
bated with irrelevant rabbit IgG.
Chromatin immunoprecipitation (ChIP)
HCT116 cells were asynchronously grown till achieve an
80% confluence. ChIP assays were then performed as previ-
ously described (18). Briefly, cells were lysed and chromatin
from cross-linked cells was sonicated. Chromatin was in-
cubated with 5 g of anti-p27, anti-PCAF or anti-PAX5
antibodies in RIPA buffer (50 mM Tris−HCl pH 7.5, 150
mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 0.1 mM
Na3VO4, 0.5 g/l aprotinin, 10 g/l leupeptin) adding
20 l of Magna ChIP Protein A magnetic beads (Milli-
pore). Samples were incubated in rotation overnight at 4◦C.
Beads were washed with low salt buffer, high salt buffer,
LiCl buffer and TE buffer. Subsequent elution and purifi-
cation of the immunoprecipitatedDNA-proteins complexes
was performed using the IPure kit (Diagenode) according to
manufacturer’s protocol. Samples were analyzed by qPCR.
The association of p27 and PCAF to their respective bind-
ing sites of the gene Grin3A, SPAG9, ROBO1 and UNC5D
was performed by RT-PCR using the primers listed in Sup-
plementary Table S1.
ChIP–seq
HCT116 cells were grown to confluence and made quies-
cent by serum starvation during 48 h for doing the ChIP-seq
for p27. In contrast, asynchronously growing HCT116 cells
were used for the ChIP-seq studies using anti-PCAF. After
DNA isolation, ChIP samples, together with the input, were
sequenced. Libraries were prepared using the NEBNext®
ChIP-Seq Library Prep Reagent Set for Illumina® kit (ref.
E6200S) according to the manufacturer’s protocol. Briefly,
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10 ng of input and ChIP enriched DNA were subjected
to end repair, addition of ‘A’ bases to 3′ ends and ligation
of PE adapters. All purification steps were performed us-
ing Qiagen PCR purification columns (refs. 50928106 and
50928006). Library size selection was done with 2% low-
range agarose gels. Library amplification was performed by
PCR on the size selected fragments. Final libraries were an-
alyzed using Agilent DNA 1000 chip to estimate the quan-
tity and check size distribution, and were then quantified
by qPCR using the KAPA Library Quantification Kit (ref.
KK4835, KapaBiosystems) prior to amplification with Illu-
mina’s cBot. Sequencingwas done on theHiSeq2000, Single
Read, 50 nts.
ChIP-seq data analysis
Illumina pipeline analyzed short reads were uniquely
aligned allowing at best two mismatches to the UCSC (The
Genome Sequencing Consortium) human genome version
hg18, using the program BOWTIE (19). Peak caller algo-
rithm MACS (version 1.4) was used to determine enriched
peak region with parameters: –nomodel, –tsize= 46, –bw=
300. Shift size were determined using Pyicos (20) strand cor-
relation method. Enriched peaks were annotated to near-
est EnsEMBL (21) gene (EnsEMBL Biomart version 54)
using Bioconductor package ChIPpeakAnno (22). Distri-
bution of enriched reads along the genomes and transcrip-
tion start site (TSS) of RefSeq genes were determined using
CEAS (23). Data from ChIP-seq experiments have been de-
posited in GEO (accession number GSE93975).
De novo motif discovery
To determine the over-represented short sequence motifs in
enriched peaks, we used total 100nt sequences (from peak
summit, 50 bp down and 50 bp up). We used top 1000
peaks (based on fold change) for finding motifs using both
WEEDER (24) and MEME (25) programs.
Functional enrichment analysis
Functional annotation of target genes is based on Gene
Ontology (GO) (26) Consortium, 2000; (http://www.
geneontology.org) as extracted from EnsEMBL (21) and
KEGG pathway database (27). Accordingly, all genes are
classified into the ontology categories biological process
(GOBP) and pathways when possible. We have taken only
the GO/pathway categories that have at least 10 genes an-
notated. We used Gitools for enrichment analysis and heat
map generation (28) (http://www.gitools.org). Resulting P-
values were adjusted for multiple testing using the Ben-
jamin andHochberg’s method of False Discovery Rate (29).
Enrichment analysis was also performed using the public
DAVID tools (Database for Annotation, visualization and
integrated discovery v 6.7) (http://david.abcc.ncifcrf.gov)
(30).
Putative transcription factor binding
Possible occurrence of transcription factor (TF) motifs in
peak regions (150 bp around peak summit), or in target gene
promoterswere predictedwith STORMalgorithm (31)with
a P-value cutoff determined based on the size of the input
sequence as (1/100× sequence-size), and using position fre-
quency matrices (PFM) from TRANSFAC database (pro-
fessional version release 2009.4).
Co-occurrence and enrichment of TFs around enriched peaks
Possible occurrence of TF motifs in peak regions (150 bp
around peak summit) and overrepresentation of these TFs
is based on the tool Pscan (32) with parameter: mixed back-
ground hg18, TRANSFAC matrix. Pscan evaluates local
enrichment, comparing with a t-test mean and standard de-
viation of the score of the best matching oligonucleotides in
the input regions tomean and standard deviation of the best
match in the genomic regions flanking the input ones. Local
enrichment can be used to identify motifs with significant
preference for binding within the regions, that is, the mo-
tif corresponding to the ChIP’ed TF, as well as other TFs
likely to interact with it and binding in its neighborhood.
Local enrichment P-value (L.PV): describing whether the
motif is over- or underrepresented in the 150 bp input re-
gions with respect to the genomic regions flanking them,
indicating whether the motif is overrepresented.
Overlap analysis
Overlap of genomic position range data was done using
BedTools (33) and significance of overlap was analyzed by
Hypergeometric test. However, Venn-diagram generation
and overlap of target genes analysis was performed using
in-house R programming language script. Significance of
overlap calculated based on Chi-square test. Unless stated,
peak overlap is defined as overlap by at least 1 bp.
RNA extraction, reverse transcription-PCR and quantitative
PCR (qPCR) for gene expression analysis
Total RNA from cells was extracted using High Pure RNA
Isolation kit (Roche). cDNA was obtained from 1 g of
RNA using SuperScript VILO cDNA synthesis (Invitro-
gen) according to manufacturer’s instructions. Gene ex-
pression was analyzed by real-time PCR, using Express
SYBRGreenER qPCR supermix (Invitrogen), corrected by
GADPH expression and expressed as relative units. Primer
sequences used for qPCR assessment of mRNA levels of
target genes are listed in Supplementary Table S2. Primer
sequences used for qPCR assessment of the primary non-
spliced transcripts of target genes are listed in Supplemen-
tary Table S3.
ShRNA lentiviral infection
HCT116 or MCF-7 cells were infected with MISSION
shRNA control vector and specific p27 or PCAF shRNA
(Sigma Aldrich) with the following sequences:
p27: 5′-CCGGGTAGGATAAGTGAAATGGATAC
TCGAGTATCCATTTCACTTATCCTACTTTTTG-3′
PCAF:5′-CCGGGCAGACTTACAGCGAGTCTTTC
TCGAGAAAGACTCGCTGTAAGTCTGCTTTT-3′
The protocol for viral particles production and cell in-
fections has been described elsewhere (34). Twenty four
Downloaded from https://academic.oup.com/nar/article-abstract/45/9/5086/2967002
by Universitat de Barcelona user
on 09 February 2018
Nucleic Acids Research, 2017, Vol. 45, No. 9 5089
hours after infection, cells were selected with 2 mg/ml of
Puromycin (Sigma Aldrich) for five days. shRNA-mediated
down-regulation was tested byWBwith specific antibodies.
CRISPR/Cas9 transfection
HCT116 cells were co-transfected with Control
CRISPR/Cas9 (sc-418922), p27 CRISPR/Cas9 KO
(sc-400074) or PCAF CRISPR/Cas9 KO (sc-400753) plas-
mids from Santa Cruz and with pLPCX plasmid (K1061-1,
Clontech) using Lipofectamine 2000 transfection reagent
(Invitrogen P/N 52887) according to manufacturer’s
protocol. Transfected cells were subsequently selected with
media containing 2 mg/ml of Puromycin (Sigma Aldrich)
for 3–5 days. Successful transfection was confirmed by
WB with specific antibodies. For the stable generation
of a p27KO cell line we used the CRISPR/Cas9 system
transfecting HCT116 cells with p27 Double Nickase Plas-
mid (sc-400074-NIC) and with Control Double Nickase
(sc-437281) for the control cell line. Individual GFP pos-
itive colonies were isolated by cell sorting (FACSAriaII)
and seeded in 96-well plates and grown for 2–3 weeks
until the positive colonies reached confluence when they
were transferred to 24-well plates. When the latter reached
confluence, cells were trypsinized and an aliquot was kept
for protein screening by WB and mRNA levels validation.
The remaining cells were frozen or expanded in 60 mm
dishes for additional analyses.
Expression microarrays
Asynchronously growing HCT116 cells were washed with
PBS and RNA was isolated from 3 different sets of cells
transfected with shRNA control or shRNAPCAF. To-
tal RNA was extracted using the RNeasy Kit (Qiagen,
Iberia,Madrid, Spain). RNAquality control was done with
Agilent 2100 bioanalyzer. Samples were then hybridized
with Affymetrix Human Gene 1.0 ST arrays. Dataset ob-
tained by Expression Console (Affymetrix) were analyzed
by DNA-ChIP Analyzer (dChIP) software and tools. The
normalization of the arrays was performed using the ro-
bust multi-array average (RMA)method as implemented in
the Affymetrix package of R bioconductor. Quality control
measurements were obtained with ArrayQualityMetrics,
while the statistical analysis of significant hits with Limma
(35). Data from expression microarray experiments have
been deposited in GEO (accession number GSE93694).
RESULTS
Differential distribution of PCAF and p27 chromatin binding
sites in HCT116 cells
To analyze the transcriptional programs regulated by p27,
ChIP-seq experiments were performed inHCT116 cells. Re-
sults showed that p27 significantly binds to the chromatin
at 1981 sites that corresponded to 1012 genes. Analysis of
p27-binding sites (p27-BSs) distribution overall genome in-
dicates that it mostly associates to distal intergenic regions
(∼74%) and to intronic sequences (∼24%). In contrast, as-
sociation with proximal and exonic regions was minimal
(Figure 1A). ChIP-seq analyses were also performed to
identify the putative PCAF-BSs. Results showed that PCAF
associates to the chromatin at 10.878 specific sites that cor-
responded to 6.131 genes. PCAFmostly associates with dis-
tal intergenic (∼42%), intronic (∼42%) and exonic (∼8%)
sequences. Interestingly, its association to proximal regions,
although low (∼4%), was much higher than p27 (Figure
1A). Because neither p27 nor PCAF interact directly with
DNA, their association with chromatin has to be mediated
by chromatin associated proteins.
We also analyzed the distribution of p27- and PCAF-
BSs over chromosomes. As shown in Supplementary Figure
S1, PCAF-BSs significantly accumulated in chromosomes
8, 10, 16, 17, 19, 20, 21 and 22. Interestingly, the distribution
of p27-BSs was quite similar. They accumulated in chromo-
somes 8, 10, 16, 17, 21 andY. It worth’s noting that the pres-
ence of both p27 and PCAF- BSs in chromosome X was ex-
tremely reduced. Finally, we also analyzed the biotype pro-
file of the genes potentially regulated by p27 or PCAF. In the
case of PCAF the 76% of the genes were encoding for pro-
teins, the 13% for pseudogenes and the remaining 11% cor-
responded to non-coding RNAs (ncRNAs) (Figure 1B). In-
triguingly, the 41% of the genes putatively regulated by p27
corresponded to nc-RNAs (23%) and to pseudogenes (18%)
and only the 59% were genes encoding for proteins (Figure
1B). These results indicate that both, p27 and PCAF, but
p27 in a higher extension, can play a significant role in the
expression of nc-RNAs and pseudogenes.
Gene ontology analysis of p27- BSs and PCAF-BSs
Gene ontology (GO) analysis of the protein encoding
genes potentially regulated by p27 was performed using the
DAVIDprogram.Results revealed that the fourmore signif-
icant biological processes were: cell adhesion, neuron differ-
entiation, cell-cell signaling and ion transport (Figure 2A).
In the case of PCAF, due the high number of peaks, the
analyses had to be done in two separated groups. One group
contained the genes with PCAF-BSs in intragenic regions
and the other included genes with PCAF-BSs in intergenic
regions. Interestingly, the four biological processes enriched
in p27-target genes (p27-TGs) were also significantly en-
riched (Figure 2B and C). We observed that around 50%
of p27-TGs in these four groups also contained PCAF-BSs
(Supplementary Figure S2). These results suggest that p27
and PCAF can collaborate in the transcriptional regulation
of genes involved in these cellular functions. To further con-
firm this data, GO analysis using the Gitools program was
additionally performed. Results showed that three of the
biological processes (cell adhesion, neuron differentiation
and ion transport) shared by p27 and PCAF-TGs were also
found to be significantly enriched using this more restrictive
program (Figure 2D).
We next aimed to identifyDNA consensus sequences that
could interact with p27 or with PCAF using the MEME
tool. These analyses allowed the identification of two con-
sensus sequences for p27 and three other sequences for
PCAF (Figure 2E).
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Figure 1. Distribution of p27- and PCAF-BSs on the chromatin. (A) Distribution of different chromatin regions overall genome of HCT116 cells (upper
panel), p27-BSs (Bottom panel, left) and PCAF-BSs (Bottom panel, right) obtained by ChIP-seq experiments. Results are represented as percentage. (B)
The different biotypes of genes putatively regulated by p27 (left) or PCAF (right) are represented as percentage.
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Figure 2. Gene ontology analysis of protein encoding genes with p27- or PCAF-BSs in their proximity. The Database for Annotation, Visualization and
Integrated Discovery (DAVID) program was used to define biological processes enriched in the protein encoding genes putatively regulated by p27 (A),
PCAF (intragenic BSs) (B) and PCAF (intergenic BSs) (C). (D) The Gitools program was used to define biological processes enriched in the protein
encoding genes putatively regulated by p27 or PCAF. (E) MEME programs were used to identify short sequence motifs enriched in the p27-BSs (upper
panel) or PCAF-BSs (bottom panel).
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Identification of protein encoding genes containing p27- and
PCAF- binding sites
By comparing the p27 and PCAF ChIP-seq data we iden-
tified 269 protein encoding genes that contain BSs for both
proteins (Figure 3A). These genes represent the 45% of all
the protein encoding p27-TGs, a percentage similar to that
observed in the four biological processes most significantly
regulated by these two proteins according to the GO analy-
sis (Supplementary Figure S2). Interestingly, in most cases,
the chromatin region able to associate with PCAF is differ-
ent to that interacting with p27. GO analysis of these 269
genes revealed that the biological processes ionic transport,
cell adhesion, and cell-cell signaling were significantly en-
riched (Figure 3B).
Expression microarrays in HCT116 cells knocked down for
PCAF
HCT116 cells were knocked down (KD) for PCAF us-
ing a specific shRNA (Supplementary Figure S3A). Then,
expression microarray analyses, in PCAF-KD cells versus
control, were performed. Results showed that 852 genes
were differentially expressed in these cells being 557 genes
up-regulated and 295 down-regulated (Figure 3C). GO
analysis revealed that the most significantly enriched group
was cell cycle (Figure 3D). Interestingly, GO analysis of
down-regulated genes revealed that most of these cell cycle
regulatory genes were down-regulated in PCAF-KD cells
(Supplementary Figure S3B). These results suggest that
PCAF regulates cell cycle progression by controlling the ex-
pression of a number of relevant cell cycle regulatory genes.
Genes up-regulated are mainly involved in translation and
apoptosis (Supplementary Figure S3C).
On comparingChIP-seq and expressionmicroarrays data
we observed that 156 genes from those differentially ex-
pressed in the PCAF-KD cells also showed PCAF-BSs sug-
gesting that PCAF participates in the regulation of the ex-
pression of these genes by associating with regulatory pro-
tein complexes at these specific sites (Figure 3E). The rest of
the genes could be genes indirectly regulated by PCAF. GO
analysis of these 156 genes showed that a significant num-
ber of them are involved in cellular functions related to cell
adhesion and neurogenesis (Supplementary Figure S3D).
We also observed that 5 of these genes (IGF1R, GABRG2,
CRBN, SPAG9 and ZWINT) also contain p27-BSs (Figure
3E).
Role of p27 and PCAF in the regulation of transcription
To define the role of p27 and PCAF on the expression
of TGs we analyzed the effect of knocking down p27
or/and PCAF on transcription of a number of selected
common targets (Table 1) using specific shRNAs (Supple-
mentary Figure S3A). Determinations were performed in
asynchronously proliferating cells (mostly in G1) thus min-
imizing the cell cycle progression differences between p27-
KD cells and PCAF-KD cells (both proliferating slightly
faster than controls) as observed by determining the gener-
ation time (Supplementary Figure S4A and B). We found
that in p27-KD cells the mRNA levels of most TGs were
increased (Figure 4A). To investigate whether these higher
levels of mRNAwere due to increased rates of transcription
we determined the amount of the primary non-spliced tran-
scripts (PNST) by qPCR. Results revealed that these tran-
scripts were elevated in p27-KD cells indicating that p27 re-
presses transcription of these genes (Figure 4B).
We also found that the mRNA levels of common TGs
were significantly lower in PCAF-KD cells than in control
cells (Figure 4C) and that this reduction was due to a de-
creased rate of transcription (Figure 4D). This indicates
that PCAF activates transcription of these TGs. To con-
firm the transcriptional regulatory role of p27 and PCAF
we performed similar experiments using the CRISPR/Cas9
methodology. Thus, after knocking out p27 (Supplemen-
tary Figure S4A) we observed that the levels of mRNA and
primary non-spliced transcripts were increased (Figures 4E
and 4F). In contrast in PCAF-KD cells the levels of mRNA
and primary non-spliced transcript were found to be de-
creased (Figure 4G and H). We analyzed the expression of
specific target genes for only p27 or PCAF as controls (Sup-
plementary Figure S5A). The protein levels in p27KO or
PCAF-KD cells were also determined (Supplementary Fig-
ure S5B).
We also investigated the effect of the double KD (2KD)
of p27 and PCAF on transcription. In 2KD-cells obtained
using shRNAs we observed that the amount of the primary
non-spliced transcripts was reduced in all the cases indi-
cating that the co-activator effect of PCAF overrides the
repressor role of p27 in all the cases (Figure 5A). These
results were corroborated by generating 2KD cells using
CRISP/Cas9 (Figure 5B). In these cells the levels of mRNA
(Figure 5C) primary non-spliced transcripts (Figure 5D)
and protein (Supplementary Figure S5C) were significantly
reduced. Additionally, KD experiments using the MCF-7
breast cancer cell line gave similar results: whereas the KD
p27 increased transcription of TGs, the KD of PCAF re-
duced their expression (Supplementary Figure S6).
PAX5 collaborates with p27 and PCAF in the regulation of
transcription
The identification of TFs that could bind to p27- and
PCAF-BSs was performed by studying 150 bp regions of
these peaks (75 bp up the maximum and 75 bp down) by
using the STORM tool for the scanning of the peaks and
the TF-BSs motif position weight matrix from TRANS-
FAC. The ten TFs more significantly identified have been
represented in a heat map that compares results from p27
and PCAF (Figure 6A). Interestingly, only PAX5 appears
to be able to significantly associate to the p27-BSs. In con-
trast, a number of different TFs can putatively associate to
the PCAF-BSs and among these different candidates PAX5
was one of the most significant (Figure 6A). Interestingly,
The consensus sequence for Pax5 (Supplementary Figure
S7) is quite similar to the sequences found for p27 and
PCAF (Figure 2E and Supplementary Figure S7). Interest-
ingly, the sequence analysis of the chromatin peaks for p27
and PCAF of a number of genes (Table 1) also revealed that
these sequences also include regions of high similarity with
the PAX5 consensus sequence (data not shown). Hence,
we aimed to analyze the putative interaction of PAX5 with
both p27 and PCAF by IP. We observed that PAX5 levels
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Figure 3. Identification of genes putatively regulated by p27 and PCAF. (A) Venn diagram representing the number of genes encoding for proteins identified
by ChIP-seq with anti-PCAF antibodies (pink) or with anti-p27 (blue). (B) The biological processes enriched in the group of genes sharing p27 and PCAF-
BSs (269 genes) were identified by using the DAVID program. (C) Number of genes differentially expressed in PCAF-KD versus control HCT116 cells
identified by expression microarray analysis and main characteristics of the data. (D) The biological processes enriched in the group of genes differentially
expressed in PCAF-KD cells versus control were identified using the DAVID program. (E) Venn diagram representing the number of genes encoding for
proteins identified by ChIP-seq with anti-PCAF antibodies (pink), with anti-p27 (blue) or differentially expressed in PCAF-KD cells (green).
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Figure 4. Effect of knocking down p27 or PCAF on the expression of target genes. (A) HCT116 cells were infected with a specific shRNA for p27 (shp27)
or with a control shRNA (sh(–)). Then, mRNA levels of different common target genes (see Table 1) were determined by qPCR. In these cells, the levels of
primary non spliced transcripts (PNST) were also determined by qPCR (B). (C) HCT116 cells were infected with a specific shRNA for PCAF (shPCAF)
or with a control shRNA (sh(–)) and the levels of mRNA of different common target genes were subsequently determined by qPCR. In these cells, the
levels of primary non spliced transcripts (PNST) were also determined by qPCR (D). Levels of mRNA (E) or of primary non spliced transcripts (PNST)
(F) from different common target genes were determined in p27 knocked down cells using the CRISPR/Cas9 (CR p27) methodology and in control cells
(CR Ctrl). Levels of mRNA (G) or of primary non spliced transcripts (PNST) (H) from different common target genes were determined in PACF knocked
down cells using the CRISPR/Cas9 (CR PCAF) methodology and in control cells (CR Ctrl). In all experiments results are the mean value ± SEM of four
independent experiments and are represented as fold enrichment versus control. Statistical analyses were performed using the t-student’s test. *P < 0.05,
**P < 0.01 and ***P < 0.001.
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Table 1. List of selected genes that have both p27 and PCAF- binding sites (BSs) in their vicinity. The table includes localization and extension of the p27-
and PCAF-BSs and the intensity of the binding (Fold-enrichment)
ChIP-seq Cromosome Start End
Fold-
enrichment Inside feature Distance to feature
GABRG2 p27 chr5 161583970 161584252 9.91 Downstream 156675
PCAF chr5 161580341 161580611 11.44 Downstream 153046
GHR p27 chr5 42434475 42434749 8.49 Upstream -25308
PCAF chr5 42267322 42267561 10.01 Upstream -192461
GRIN3A p27 chr9 103520403 103520670 8.49 Inside 20280
PCAF chr9 103539425 103539691 8.58 Inside 1258
IGF1R p27 chr15 97121406 97121648 9.91 Inside 111104
PCAF chr15 97135969 97136244 11.86 Inside 125667
PCAF chr15 96961148 96961421 8.46 Upstream -49154
ROBO1 p27 chr3 79257543 79257776 9.83 Upstream -163
PCAF chr3 80182644 80183002 11.44 Upstream -460893
PCAF chr3 80060831 80061238 10.15 Upstream -339080
UNC5D p27 chr8 35345752 35346062 8.49 Inside 132907
p27 chr8 35652578 35652839 8.49 Inside 131126
PCAF chr8 35828412 35828659 8.58 Downstream 306960
IL7 p27 chr8 80047436 80047703 11.32 Upstream -167123
p27 chr8 80007304 80007574 9.91 Upstream -126991
PCAF chr8 79892345 79892640 7.98 Upstream -12032
ARHGEF7 p27 chr13 110645835 110646168 6.97 Upstream -9802
PCAF chr13 110492766 110493092 10.15 Upstream -73017
RERGL p27 chr12 18151836 18152131 11.32 Upstream -17455
PCAF chr12 17993973 17994265 12.87 Downstream 140408
SPAG9 p27 chr17 46415723 46416022 8.9 Inside 63547
PCAF chr17 46406076 46406443 8.87 Inside 73194
CRBN p27 chr3 3355488 3355749 9.64 Upstream -159098
p27 chr3 3328299 3328565 11.32 Upstream -131909
PCAF chr3 3417081 3417428 11.44 Upstream -220691
GLI3 p27 chr7 42180561 42180853 11.32 Inside 48859
PCAF chr7 42190975 42191217 8.12 Inside 38445
ZNF716 p27 chr7 57555151 57555705 7.79 Downstream 41320
PCAF chr7 57555035 57555523 7.7 Downstream 41204
DGCR6 p27 chr22 17263635 17264251 9.48 Upstream -10144
PCAF chr22 17263972 17264283 8.79 Upstream –9807
are constant along cell cycle (Supplementary Figure S8A).
IP experiments using anti-PAX5 were performed in asyn-
chronously growingHCT116 cells. Results revealed that this
protein interacts with both p27 and PCAF (Figure 6B).
Also reciprocal IPs using anti-p27 and anti-PCAF showed
this interaction (Supplementary Figure S8B and C). Inter-
estingly, the absence of PCAF did not affect the interac-
tion between PAX5 and p27 (Supplementary Figure S8D).
Similarly, the absence of p27 did not alter the association
between PAX5 and PCAF (Supplementary Figure S8E).
These results suggest that PAX5 is able to bind to both (p27
and PCAF), most probably through different binding sites
because in the absence of p27 the levels of PCAF associated
to PAX5 are quite similar to those associated in its presence
(Supplementary Figure S8E). The interaction of p27 with
its specific binding site in the GRIN3A, SPAG9, ROBO1
and UNC5D genes was validated by ChIP in HCT116 cells
(Figure 6C, upper panel). Additionally, the specificity of the
interaction was validated by ChIP in HCT116 p27KO cells
(Supplementary Figure S9A). Moreover, the interaction of
PCAF with its specific binding site in the same genes was
also validated by ChIP (Figure 6C bottom panel). Next,
ChIP analysis with anti-PAX5 showed the binding of PAX5
to the p27- and PCAF-BSs of the same group of genes (Fig-
ure 6D) indicating that PAX5 is able to associate to both
p27 and PCAF-BSs. Finally, ChIP experiments performed
in HCT116 cells knocked down for PAX5 revealed a sig-
nificant decreased association of p27 and PCAF to their re-
spective binding sites, suggesting that PAX5mediates the in-
teraction of both proteins with DNA (Supplementary Fig-
ure S9B). Interestingly, we observed that the mRNA and
the protein levels of several target genes were increased in
PAX5-KD cells (Figure 6E, F and G). All these data indi-
cate that PAX5 collaborates in the transcriptional regula-
tion of specific p27 and PCAF target genes playing a role as
a repressor.
DISCUSSION
PCAF is a member of the GNAT (GCN5-related N-
acetyltransferases) family of acetylases that participates in
large multi-subunit complexes involved in transcriptional
regulation (36). It also possesses an intrinsic ubiquitin E3
ligase activity that allows specific ubiquitylation of tar-
get proteins (37). PCAF behaves as a transcriptional co-
activator by acetylating a number of different substrates,
the most well-known being histones, although non-histones
proteins are also substrates of PCAF (36). These include
TFs as c-myc, E2F1, GATA-2 and Myo-D (38–41), other
proteins involved in transcription as Cdk9 and some cell cy-
cle regulatory proteins as p27, cdk2 and cyclin A (6,42–44).
The evidence showing that PCAFacetylates p27 inducing
its degradation (6) and that p27 behaves as a transcriptional
repressor (9,11) suggested the possibility of the cooperation
between both proteins in the regulation of transcription.We
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Figure 5. Effect of knocking down both, p27 and PCAF on the expression of target genes. (A) HCT116 cells were infected with a specific shRNA for p27
alone, or with shRNAs for p27 and PCAF or with a control shRNA (sh(–)). Then, the levels of primary non spliced transcripts (PNST) were determined by
qPCR. (B). Cells were Knocked down for p27 and PCAF (double knockout) (2KD) using the CRISPR/Cas9 methodology. Then, the levels of PCAF and
p27 were determined by WB. Levels of mRNA (C) or of primary non spliced transcripts (PNST) (D) from different common target genes were determined
in double knock down cells (CR 2KD) and in control cells (CR Ctrl) by qPCR. In all experiments results are the mean value ± SEM of four independent
experiments and are represented as fold enrichment versus control. Statistical analyses were performed using the t-student’s test. *P < 0.05, **P < 0.01
and ***P < 0.001.
analyzed this possibility by performing ChIP-seq analysis
in HCT116 cells using both anti-PCAF and anti-p27 anti-
bodies. The first interesting observation was that the distri-
bution of the binding sites of both proteins overall genome
was very different. Intriguingly, only a small number of p27-
BSs were on gene promoters while most of themwere in dis-
tal intergenic (74%) or in intronic regions (24%). These re-
sults expand the previous information of the identification
of p27-BSs performed by ChIP on chip in NIH3T3 cells in
which only the association of p27 with gene promoters was
analyzed (9) and reveals for the first time that the role of p27
in the regulation of transcription is mainly produced by as-
sociating to chromatin regions distal from the promoters.
In contrast, around the 60% of the PCAF-BSs were on the
gene body (intron and exon regions) or in proximal regions.
Another attractive observation was that a significant
number of the p27-BSs (40%) were close to pseudogenes
or sequences of non-coding RNAs. Similar results were ob-
served for PCAF although the proportion was lower (25%).
This observation suggests a putative role of both proteins in
the regulation of ncRNA and pseudogene expression. Due
to the relevance of these types of RNAs in multiple cellular
functions and their involvement in different pathologies, as
for instance cancer, these data reveal a putative new role of
p27 and PCAF as transcriptional regulators of these RNAs
(45–48).
Results reported here also yield up that both p27 and
PCAF proteins regulate the expression of similar functional
groups of genes as cell adhesion, neuronal differentiation,
ion transport and cell signaling. It’s worth noting that the
45%of protein-encoding p27-TGs also contain PCAFbind-
ing sites indicating that this transcriptional co-activator
could be a very important partner of p27 in the regulation of
transcription. In fact, we demonstrate here the cooperation
between these two proteins in the regulation of transcription
of a number of common targets. Specifically, by knocking
down p27, PCAF or both we have seen that PCAF operates
as a co-activator and p27 as a repressor and that PCAF is
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Figure 6. PAX5 collaborates in the regulation of p27- and PCAF-target genes. (A) Enrichment analysis of the putative transcription factors that could
significantly associate to p27- or PCAF-BSs was performed using GiTools, the STORM tool for the scanning of the peaks and the TF-BSs motif position
weight matrix from TRANSFAC. (B) IP experiments were performed using anti-PAX5 antibodies or IgG as a control. The presence of p27, PAX5 and
PCAF in the inputs and in the immunoprecipitates was determined by WB. (C) The interactions of p27 (upper panel) or PCAF (bottom panel) with their
specific chromatin binding sites in several target genes were performed by ChIP using anti-p27, anti-PCAF or no-antibodies as a control. Results are
represented relative to the control. (D) The interaction of PAX5 with the p27- BSs (upper panel) and PCAF-BSs (bottom panel) of the target genes was
analyzed by ChIP using anti-PAX5 antibodies or no-antibodies as a control. Results are represented relative to the control (E) Cells were infected with
a specific shRNA for PAX5 or a control shRNA. Then, the levels of PAX5 mRNA (upper panel) and PAX5 protein (bottom panel) were determined by
qPCR or WB, respectively. (F) The mRNA levels of different target genes were determined by qPCR in cells infected with a specific shRNA for PAX5
(white bars) or a control shRNA (black bars). Results are represented as a fold change relative to the control. In all cases, results are the mean value ±
SD of three independent experiments. Statistical analyses were performed using the t-student’s test. *P < 0.05, **P < 0.01 and ***P < 0.001. (G) Protein
levels of the different TGs were determined by WB in PAX5-KD cells. Tubulin was used as a loading control.
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needed for the expression of p27-TGs because in the double
knock-down cells gene expression is blocked. Curiously, in
this cooperative role each one of these proteins associates to
different regulatory sites of the chromatin.
The evidence that PCAF acetylates K100 sited inD2 sub-
domain of p27 and that this acetylation induces p27 ubiq-
uitylation and the subsequent degradation (6) together with
results reported here allows us to postulate a model of how
p27 and PCAF can cooperate in the regulation of tran-
scription. In this model, p27 associated to specific regula-
tory domains of the chromatin represses transcription of
its target genes. To activate transcription PCAF (associated
to a different regulatory domain) interacts with p27, possi-
ble by a change in chromatin conformation. Then, PCAF
acetylates p27 inducing its degradation. Whether the p27-
ubiquitylating enzyme is the own PCAF still remains un-
known but this is an attractive possibility. Degradation of
p27 would eliminate the repressor role of this protein and
would allow PCAF to act as a transcriptional co-activator.
That PCAF mediated acetylation occurs on p27 associated
to the regulatory chromatin BSs still remains to be demon-
strated. However, a similar mechanism has been reported
to operate during the activation of the Hedgehog pathway
(49). Authors described that cells subjected to a genotoxic
stress induce the p53-dependent transcriptional activation
and accumulation of PCAF (50). Then, PCAF associates
with and acetylates the TF GLI1 that is subsequently ubiq-
uitylated by the intrinsic ubiquitin E3 ligase of PCAF that
induced its degradation. As a consequence, GLI1 targets
cannot be transcribed.
We also report here that PAX5 participates in the tran-
scriptional regulation mediated by p27 and PCAF. PAX5
belongs to the PAX family of TFs that include 9 members
that are involved in the control of development (51). Specif-
ically, PAX5 is essential for commitment of lymphoid pro-
genitors to the B lymphocyte lineage. It activates the ex-
pression of B-lineage specific genes but represses a subset
of genes not needed for this process of differentiation (52).
Interestingly, mice lacking PAX5 in mature B cells develop
aggressive lymphomas (53). We report here that PAX5 in-
teracts with both p27 and PCAF, that it associates to p27-
and PCAF-BSs and that the knockdown of PAX5 increased
transcription of p27/PCAF-TGs indicating that it behaves
as a transcriptional repressor of these genes together with
p27. An attractive speculation is that PAX5, similarly to
p27, could be a PCAF substrate and that PAX5 acetyla-
tion could lead to its inactivation as a transcriptional re-
pressor. However, this possibility remains to be explored.
In summary, we describe here a novel mechanism of tran-
scriptional regulation mediated by p27, PAX5 and PCAF
that might be relevant for the control of several important
biological processes and that can participate in the devel-
opment of different pathological situations as for instance
tumorigenesis.
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